U.S. Trade Distributors Stock News

Why Host Hotels & Resorts Is Back on Investors’ Radar Host Hotels & Resorts (HST) has drawn fresh attention after a solid stretch of share gains, including around 9% over the past month and about 21% in the past 3 months. Those moves come alongside annual revenue of roughly US$5.95b and net income of about US$738m, prompting investors to reassess what they are paying today for one of the largest lodging REITs in the S&P 500. See our latest analysis for Host Hotels & Resorts. Beyond the recent...

Comparor has announced the launch of its AI-powered shopping assistant, a tool designed to streamline the online shopping process by offering instant product recommendations and real-time price comparisons across multiple retailers. This solution leverages artificial intelligence to process natural language requests and deliver optimized shopping options, helping users save time and make more informed purchasing decisions. As an emerging trend in e-commerce, AI-enabled tools like Comparor’s...

Artivion, Inc.'s ( NYSE:AORT ) earnings announcement last week was disappointing for investors, despite the decent...

Investors signalled that they were pleased with Cognex Corporation's ( NASDAQ:CGNX ) most recent earnings report. This...

W. R. Berkley Corporation ( NYSE:WRB ) is about to trade ex-dividend in the next three days. The ex-dividend date is...

Somnigroup International (SGI) released fourth quarter and full year 2025 results alongside a cautious 2026 outlook, combining strong reported revenue figures with earnings guidance that fell short of market expectations and stirred investor concern. See our latest analysis for Somnigroup International. The mixed earnings release and cautious 2026 guidance prompted a sharp single day drop earlier in the week, and the 7 day share price return of 7.22% reflects that reset. However, the 12 month...

If you are wondering whether J&J Snack Foods is priced fairly right now or offering value at a discount, this article will walk through what the numbers are actually saying. The stock recently closed at US$84.87, with returns of 3.1% over 7 days, a 12.6% decline over 30 days, a 6.2% decline year to date, and a 30.0% decline over 1 year. These moves can change how the market views both its growth potential and risk. Recent coverage of J&J Snack Foods has focused on its role in the frozen and...

It looks like Johnson & Johnson ( NYSE:JNJ ) is about to go ex-dividend in the next 4 days. The ex-dividend date occurs...

Jana Partners has built a significant stake in Fiserv and is publicly pushing for operational and governance changes. The activist investor is calling for a review of non core businesses and potential board refreshment. Jana has voiced support for CEO Mike Lyons' ongoing turnaround efforts while urging a fresh look at the company's structure. For existing and potential shareholders in NasdaqGS:FISV, this intervention comes after a mixed share price record. The stock closed at $63.01, with a...

In early February 2026, Equity Residential reported its fourth-quarter and full-year 2025 results, showing higher annual sales and earnings, issued first-quarter and full-year 2026 EPS guidance of US$0.29–US$0.33 and US$1.44–US$1.56 respectively, and disclosed that it has repurchased 3,400,000 shares for US$205.7 million under a long-running buyback program. The combination of growing full-year 2025 earnings and continued buybacks, with more than 98% of the authorized repurchase plan now...

Expand Energy (EXE) just delivered quarterly earnings and revenue above analyst expectations, supported by higher production, stronger cash flow and lower breakeven costs in its Haynesville operations, alongside new 2026 production and capital allocation plans. See our latest analysis for Expand Energy. Despite the earnings beat and updated 2026 production plans, the share price has eased recently, with a 90 day share price return of 13.08% and a year to date share price decline of 9.34%,...

IDACORP recently drew fresh attention after Aristotle Capital Boston added the Idaho-based electric utility to its portfolio, praising strong industrial load growth, regional transmission opportunities, and a robust five-year capital investment plan. The asset manager’s emphasis on constructive regulation, expanding rate base, and long-term earnings potential has sharpened investor focus on IDACORP’s growth and infrastructure story ahead of its Q4 2025 results release and earnings call held...

Jefferies recently began covering Definium Therapeutics, highlighting Phase IIb data showing a single dose of lead candidate DT120 achieved a 48% remission rate in generalized anxiety disorder and assigning strong confidence in its upcoming Phase III trials. At the same time, strong late-stage results and regulatory progress for COMP360 at Compass Pathways have lifted sentiment across the psychedelics space, indirectly enhancing investor attention on Definium’s clinical pipeline. Next, we’ll...

Andersons (ANDE) has just wrapped up FY 2025 with fourth quarter revenue of US$2.5 billion, basic EPS of US$1.98 and net income of US$67.4 million. Trailing twelve month revenue came in at about US$11.0 billion with EPS of US$2.81. Over recent quarters the company has seen quarterly revenue move between US$2.5 billion and US$3.1 billion, with EPS ranging from close to flat at US$0.01 in Q1 2025 to US$1.98 in Q4. This creates a backdrop where modest net profit margins and small shifts in...

On February 6, 2026, JP Morgan downgraded MSC Industrial Direct to Neutral, expressing concern that its self-help initiatives have not delivered clear operational benefits. Just weeks earlier, shareholders had strongly re-elected all ten directors, highlighting solid support for the same management team now facing renewed scrutiny over execution. Next, we will examine how JP Morgan’s concern over MSC’s self-help efforts could influence the company’s existing investment narrative. The...

ResMed (RMD) is back in focus after a strong fiscal Q2, where its Masks & Accessories and Devices businesses outperformed expectations and analysts responded by lifting their financial outlook and maintaining positive coverage. See our latest analysis for ResMed. ResMed’s share price has moved to US$258.91, with a 6.15% 90 day share price return and a 1 year total shareholder return of 11.4%. This suggests momentum has been building around its recent Q2 beat and margin guidance. If this Q2...

United Airlines Holdings (UAL) is back in focus after committing to 300 GE Aerospace GEnx engines for its Boeing 787 Dreamliners and widening its Starlink partnership, a twin move centered on fleet efficiency and passenger connectivity. See our latest analysis for United Airlines Holdings. These engine and connectivity commitments come after a busy few weeks, with United agreeing to invest $100 million in Azul S.A., bidding $30.2 million for Spirit’s O’Hare gates, and preparing to present at...

Avient Corporation's ( NYSE:AVNT ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...

CRISPR Therapeutics (NasdaqGM:CRSP) is seeing wider use of its gene editing therapy Casgevy, with more patients starting treatment and broader reimbursement access in the U.S. and abroad. The company is reporting progress across its in vivo editing programs and siRNA pipeline, signaling activity beyond its core hematology focus. These updates point to shifting business fundamentals for CRISPR Therapeutics that have not yet been discussed in our prior coverage. CRISPR Therapeutics focuses on...

Even though DexCom, Inc.'s ( NASDAQ:DXCM ) recent earnings release was robust, the market didn't seem to notice. Our...

As February 2026 begins, U.S. stock markets have shown resilience with major indices like the Dow Jones and S&P 500 ending sharply higher, buoyed by positive economic indicators such as an unexpected expansion in factory activity. In this dynamic environment, small-cap stocks present intriguing opportunities for investors seeking value and growth potential, especially when insider actions suggest confidence in a company's prospects amidst broader market optimism.

As February begins, the U.S. stock market has shown strength with major indices like the Dow Jones and S&P 500 posting significant gains, signaling a positive start to the month despite ongoing economic uncertainties and geopolitical developments. In this environment, high-growth tech stocks in the U.S. market continue to attract attention for their potential to leverage technological advancements and shifting consumer demands, making them noteworthy considerations for investors looking to...

As February 2026 begins, the U.S. stock market shows a robust start with major indices like the Dow Jones Industrial Average and S&P 500 posting significant gains. In this environment of renewed optimism, identifying stocks that may be trading below their estimated value can offer intriguing opportunities for investors looking to capitalize on potential growth amid favorable market conditions.

The market was pleased with the recent earnings report from Insight Enterprises, Inc. ( NASDAQ:NSIT ), despite the...